HER2/Neu Status

Known as: ERBB2 Status, Her2/Neu Value 
The presence or absence of Her2/Neu on a tissue sample.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1988-2015
01219882015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The Her2/neu oncoprotein, also known as (NEU, EGFR2, or ERBB2) is one of the members of the Epidermal Growth Factor Receptor… (More)
Is this relevant?
2013
2013
Basal breast cancer comprises ~15% of invasive ductal breast cancers, and presents as high-grade lesions with aggressive clinical… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
Background:We evaluated shedding of epidermal growth factor type II receptor (Her2/neu) extracellular domain (ECD) in primary… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2011
2011
10 Background: Fine needle aspiration (FNA) cytology is a common diagnostic tool in breast cancer used to establish diagnoses of… (More)
Is this relevant?
2008
2008
Pagetoid dyskeratosis (PD) is considered a selective keratinocytic response in which a small part of the normal population of… (More)
Is this relevant?
2007
2007
BACKGROUND AND OBJECTIVE To investigate the prognostic value of p53 and HER2/neu overexpression in epithelial ovarian cancer (EOC… (More)
Is this relevant?
2002
2002
Overexpression of the oncogene HER2/neu (c-erbB-2) occurs in up to 30% of breast cancers and is correlated with reduced survival… (More)
Is this relevant?
Review
1998
Review
1998
Little information is available on the molecular mechanisms underlying neuroendocrine tumorigenesis. To obtain an overview of the… (More)
Is this relevant?
Highly Cited
1993
Highly Cited
1993
The HER2/neu oncogene encodes a transmembrane protein that possesses intrinsic tyrosine kinase activity. Its overexpression has… (More)
Is this relevant?
1988
1988
The HER2/neu protooncogene was found to be amplified in 6 of 109 primary adenocarcinoma tumors. No HER2/neu amplification was… (More)
Is this relevant?